Levetiracetam, Attention Deficits and Subclinical EEG Spikes

Abstract

The effects of levetiracetam on neuropsychological functioning in six children (mean age 9.8 years) with attention and learning difficulties and subclinical EEG spikes without clinical seizures were determined in a prospective, open-label pilot study at the Clinical Research Center of New Jersey and Drexel University, Philadelphia, PA.

Keywords

• levetiracetam
• subclinical eeg spikes
• attention and learning difficulties